Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 38713 

Guy by email: guyr2@niehs.nih.gov by 

August 29, 2018. 

Meeting Materials: The preliminary 

meeting agenda is available on the 

meeting web page https://

ntp.niehs.nih.gov/go/32822 and will be 

updated one week before the meeting. 

Individuals are encouraged to access the 

meeting web page to stay abreast of the 

most current information regarding the 

meeting. 

Background Information on ICCVAM, 

NICEATM, and SACATM: ICCVAM is 

an interagency committee composed of 

representatives from 16 federal 

regulatory and research agencies that 

require, use, generate, or disseminate 

toxicological and safety testing 

information. ICCVAM conducts 

technical evaluations of new, revised, 

and alternative safety testing methods 

with regulatory applicability and 

promotes the scientific validation and 

regulatory acceptance of toxicological 

and safety-testing methods that more 

accurately assess the safety and hazards 

of chemicals and products and that 

reduce, refine (decrease or eliminate 

pain and distress), or replace animal 

use. The ICCVAM Authorization Act of 

2000 (42 U.S.C. 285l–3) established 

ICCVAM as a permanent interagency 

committee of the NIEHS under 

NICEATM. 

NICEATM administers ICCVAM, 

provides scientific and operational 

support for ICCVAM-related activities, 

and conducts independent validation 

studies to assess the usefulness and 

limitations of new, revised, and 

alternative test methods and strategies. 

NICEATM and ICCVAM work 

collaboratively to evaluate new and 

improved test methods and strategies 

applicable to the needs of U.S. federal 

agencies. NICEATM and ICCVAM 

welcome the public nomination of new, 

revised, and alternative test methods 

and strategies for validation studies and 

technical evaluations. Additional 

information about ICCVAM and 

NICEATM can be found at http://

ntp.niehs.nih.gov/go/iccvam and http:// 

ntp.niehs.nih.gov/go/niceatm. 

SACATM was established in response 

to the ICCVAM Authorization Act 

[Section 285l–3(d)] and is composed of 

scientists from the public and private 

sectors. SACATM advises ICCVAM, 

NICEATM, and the Director of the 

NIEHS and NTP regarding statutorily 

mandated duties of ICCVAM and 

activities of NICEATM. SACATM 

provides advice on priorities and 

activities related to the development, 

validation, scientific review, regulatory 

acceptance, implementation, and 

national and international 

harmonization of new, revised, and 

alternative toxicological test methods. 

Additional information about 

SACATM, including the charter, roster, 

and records of past meetings, can be 

found at http://ntp.niehs.nih.gov/go/ 

167. 

Dated: July 24, 2018. 

Brian R. Berridge, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2018–16840 Filed 8–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Interagency Autism 

Coordinating Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Type of Meeting: Open Meeting. 

Date: Wednesday, October 17, 2018. 

Time: 9:00 a.m. to 5:00 p.m. *Eastern 

Time* Approximate end time. 

Agenda: To discuss business, updates, and 

issues related to ASD research and services 

activities. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Room C and D, 

Rockville, MD 20852. 

Webcast Live: https://videocast.nih.gov. 

Conference Call Access: Dial: 800–369– 

3190. 

Access Code: 1724926. 

Cost: The meeting is free and open to the 

public. 

Registration: A registration web link will 

be posted on the IACC website 

(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended to expedite 

check-in. Seating in the meeting room is 

limited to room capacity and on a first come, 

first served basis. Onsite registration will also 

be available. 

Deadlines: Notification of interest to 

present oral comments: Friday, October 5, 

2018 by 5:00 p.m. ET 

Submission of written/electronic statement 

for oral comments: Tuesday, October 9, 2018 

by 5:00 p.m. ET 

Submission of written comments: Tuesday, 

October 9, 2018 by 5:00 p.m. ET 

For IACC Public Comment guidelines 

please see: https://iacc.hhs.gov/meetings/ 

public-comments/guidelines/ 

Access: White Flint Metro Station (Red 

Line) in combination with a brief walk. 

Contact Person: Ms. Angelice Mitrakas, 

Office of Autism Research Coordination, 

National Institute of Mental Health, NIH, 

6001 Executive Boulevard, Room 6182A, 

Bethesda, MD 20892–9669, Phone: 301–435– 

9269, Email: IACCPublicInquiries@

mail.nih.gov. 

Public Comments: Any member of the 

public interested in presenting oral 

comments to the IACC must notify the 

Contact Person listed on this notice by 

5:00 p.m. ET on Friday, October 5, 2018 

with their request to present oral 

comments at the meeting, and a written/ 

electronic copy of the oral presentation/ 

statement must be submitted by 5:00 

p.m. ET on Tuesday, October 9, 2018. A 

limited number of slots for oral 

comment are available, and in order to 

ensure that as many different 

individuals are able to present 

throughout the year as possible, any 

given individual only will be permitted 

to present oral comments once per 

calendar year (2018). Only one 

representative of an organization will be 

allowed to present oral comments in 

any given meeting; other representatives 

of the same group may provide written 

comments. If the oral comment session 

is full, individuals who could not be 

accommodated are welcome to provide 

written comments instead. Comments to 

be read or presented in the meeting will 

be assigned a 3–5 minute time slot 

depending on the number of comments, 

but a longer version may be submitted 

in writing for the record. Commenters 

going beyond their allotted time in the 

meeting may be asked to conclude 

immediately in order to allow other 

comments and presentations to proceed 

on schedule. 

Any interested person may submit 

written public comments to the IACC 

prior to the meeting by emailing the 

comments to IACCPublicInquiries@

mail.nih.gov or by submitting comments 

at the web link: https://iacc.hhs.gov/ 

meetings/public-comments/submit/ 

index.jsp by 5:00 p.m. ET on Tuesday, 

October 9, 2018. The comments should 

include the name, address, telephone 

number, and when applicable, the 

business or professional affiliation of 

the interested person. National Institute 

on Mental Health (NIMH) anticipates 

written public comments received by 

5:00 p.m. ET on Tuesday, October 9, 

2018 will be presented to the IACC prior 

to the meeting for the IACC’s 

consideration. Any written comments 

received after the 5:00 p.m. ET, October 

9, 2018 deadline through October 15, 


daltland on DSKBBV9HB2PROD with NOTICES
38714 Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 

2018 will be provided to the IACC either 

before or after the meeting, depending 

on the volume of comments received 

and the time required to process them 

in accordance with privacy regulations 

and other applicable Federal policies. 

All written public comments and oral 

public comment statements received by 

the deadlines for both oral and written 

public comments will be provided to 

the IACC for their consideration and 

will become part of the public record. 

Attachments of copyrighted 

publications are not permitted, but web 

links or citations for any copyrighted 

works cited may be provided. 

In the 2016–2017 IACC Strategic Plan, 

the IACC listed the ‘‘Spirit of 

Collaboration’’ as one of its core values, 

stating that, ‘‘We will treat others with 

respect, listen with open minds to the 

diverse views of people on the autism 

spectrum and their families, 

thoughtfully consider community input, 

and foster discussions where 

participants can comfortably where 

participants can comfortably offer 

opposing opinions.’’ In keeping with 

this core value, the IACC and the NIMH 

Office of Autism Research Coordination 

ask that members of the public who 

provide public comments or participate 

in meetings of the IACC also seek to 

treat others with respect and 

consideration in their communications 

and actions, even when discussing 

issues of genuine concern or 

disagreement. 

Remote Access: The meeting will be 

open to the public through a conference 

call phone number and webcast live on 

the internet. Members of the public who 

participate using the conference call 

phone number will be able to listen to 

the meeting but will not be heard. If you 

experience any technical problems with 

the webcast or conference call, please 

send an e- mail to IACCPublicInquiries@

mail.nih.gov or call 240–668–0302. 

Individuals wishing to participate in 

person or by using these electronic 

services and who need special 

assistance, such as captioning of the 

conference call or other reasonable 

accommodations, should submit a 

request to the Contact Person listed on 

this notice at least five days prior to the 

meeting. 

Security: Visitors will be asked to 

show one form of identification (for 

example, a government-issued photo ID, 

driver’s license, or passport) and to state 

the purpose of their visit. Also, as a part 

of security procedures, attendees should 

be prepared to present a photo ID at the 

meeting registration desk during the 

check-in process. Pre-registration is 

recommended. Seating will be limited 

to the room capacity and seats will be 

on a first come, first served basis, with 

expedited check-in for those who are 

pre-registered. 

Meeting schedule subject to change. 

Information about the IACC is available 

on the website: http://www.iacc.hhs.gov. 

Dated: August 1, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16794 Filed 8–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

meeting of the Council of Councils. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://videocast.

nih.gov). 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4), and 552b(c)(6), Title 5 

U.S.C., as amended. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Council of Councils. 

Open: September 7, 2018. 

Time: 8:15 a.m. to 12:15 p.m. 

Agenda: Call to Order and Introductions; 

Announcements and Updates; Environmental 

influences on Child Health Outcomes 

(ECHO), Program Genetics and Epigenetics 

Research to be Supported by Future ECHO 

Genetics Core; All of Us Research Program 

Update; NIH Update; Common Fund 

Program—Stimulating Peripheral Activity to 

Address Conditions. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 60/Cloisters, Lecture 

Hall/Chapel, Bethesda, MD 20892. 

Closed: September 7, 2018. 

Time: 12:25 p.m. to 1:25 p.m. 

Agenda: Review of Grant Applications. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 60/Cloisters, Lecture 

Hall/Chapel, Bethesda, MD 20892. 

Open: September 7, 2018. 

Time: 1:25 p.m. to 4:30 p.m. 

Agenda: Council Operating Procedures; 

Workshop Report on Contributions of Social 

and Behavioral Research in Addressing the 

Opioid Crisis; Retiring Council Members’ 

Perspectives. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 60/Cloisters, Lecture 

Hall/Chapel, Bethesda, MD 20892. 

Contact Person: Franziska Grieder, D.V.M., 

Ph.D., Executive Secretary, Council of 

Councils Director, Office of Research 

Infrastructure Programs, Division of Program 

Coordination, Planning, and Strategic 

Initiatives, Office of the Director, NIH, 6701 

Democracy Boulevard, Room 948, Bethesda, 

MD 20892, GriederF@mail.nih.gov, 301–435– 

0744. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Council of Council’s home page at http://

dpcpsi.nih.gov/council/ where an agenda 

will be posted before the meeting date. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: August 1, 2018. 

David D. Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16792 Filed 8–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 


daltland on DSKBBV9HB2PROD with NOTICES